Sub Heading

Clinical Trials Details

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

IRB Protocol Number
A012303

Clinical Trial Categories

  • Breast Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Men and women 18+ years old, with diagnosis of early-stage HER2+ breast cancer, must have completed at least 12 weeks of preoperative chemotherapy, and surgery found no residual disease.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.